Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide Implant vs Sandostatin LAR in Acromegaly
NCT00765323Phase 3Terminated
- Sponsor
- Endo International plc
- Start
- Sep 2008
- Primary completion
- Feb 2011
- Modality
- Peptides
- Countries
- 9
01
Overview
A Phase 3 trial of Octreotide long-acting injection in acromegaly, sponsored by Endo International plc. Started Sep 2008; status: terminated.
02
Drugs
Octreotide long-acting injection
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT00765323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00765323.